← Browse by Condition
Medical Condition

pleural mesothelioma

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2
NCT06362369 Phase 1, Phase 2
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Enrollment
126 pts
Location
United States
Sponsor
7 Hills Pharma, LLC
View Trial →
NCT05628376
Recruiting

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

Enrollment
600 pts
Location
United Kingdom
Sponsor
University College, London
View Trial →
NCT05086692 Phase 1, Phase 2
Recruiting

A Beta-only IL-2 ImmunoTherapY Study

Enrollment
115 pts
Location
United States, Austr...
Sponsor
Medicenna Therapeutics, Inc.
View Trial →
NCT06410625
Recruiting

Evaluation of Response by FLT PET in Mesothelioma

Enrollment
25 pts
Location
Turkey (Türkiye)
Sponsor
Ankara University
View Trial →